Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: A systematic review and meta-analysis

Objectives: To meta-analyse the clinical efficacy of piperacillin-tazobactam vs. carbapenems for treating hospitalized patients affected by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales bloodstream infections (BSIs). Methods: Two authors independently searched PubMed-MEDLINE and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Milo Gatti, Pier Giorgio Cojutti, Federico Pea
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-12-01
Colecção:	Journal of Global Antimicrobial Resistance
Assuntos:	Esbl-producing Enterobacterales Bloodstream infections Piperacillin-tazobactam Carbapenems Mortality rate
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2213716524001541
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!